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Background: Despite the increasing use of transradial techniques for cardiac percutaneous procedures, none of
the strategies commonly utilized for hemostasis has been able to reduce the occurrence of radial artery occlusion
(RAO). The aim of this study was to evaluate the occurrence of 24-hour RAO and the rate of bleeding of a novel
hemostatic device for radial closure after percutaneous interventions, in adjunct to short-time compression.
Methods: Once the radial access was obtained, patients were randomized to 3 different strategies of radial closure:
a short compression with the QuikClot R© InterventionalTM pad (Z-Medica Corporation, Wallingford, CT, USA)
(15 minutes, group 1), a short compression (15 minutes, group 2), and a conventional prolonged compression
(2 hours, group 3) both without QuikClot R© utilization.
Results: Fifty patients in group 1, 20 in group 2, and 50 in group 3 were enrolled. The three groups were homogenous
for baseline and procedural characteristics. None of patients in group 1 developed RAO, 1 (5%) occurred in group
2, and 5 (10%) in group 3 (P = 0.05). Active bleeding after compression removal occurred in 10 patients (20%)
in group 1, 18 (90%) in group 2, and 1 (2%) in group 3 (P < 0.001). Among patients in group 1, at univariate
analysis, the predictors of acute bleeding resulted in chronic therapy with clopidogrel (Odds Ratio 28.78, 95%
Confidence Intervals 4.79–172.82, P < 0.001) and high levels of activated clotting time (ACT) at the time of sheath
removal (OR 1.02, 95% CI 1.00–1.03, P= 0.009). At ROC analysis, the cutoff value of ACT for the risk of bleeding
with a sensitivity of 80% and specificity of 75% was 287 seconds.
Conclusions: Early sheet removal and short-time compression with QuikClot R© InterventionalTM can reduce the
rate of RAO after diagnostic or interventional procedures especially in patients not on double antiplatelet therapy.
(J Interven Cardiol 2011;24:65–72)
Introduction
Transradial access for percutaneous cardiovascular
procedures provides a low rate of local complications
and similar clinical results compared to other sites of
access.1–3 Sheath removal after transradial catheteriza-
tion is conventionally based on external compression
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achieved with a simple bandage applied to the
entry site.4 Observational studies have shown that
prolonged or aggressive compression techniques favor
local complications such as radial artery occlusion
(RAO).4,5 RAO is relatively infrequent (5%–10%
of cases)6,7 and usually considered as a quiescent
complication of transradial procedures because of the
dual circulation of the palmar arch. Yet, its occurrence
precludes future transradial access forcing the shift
to the femoral access, which is responsible for more
bleeding complications and prolonged hospitalization
as well as greater discomfort for the patient. Therefore,
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it seems reasonable to preserve radial patency by keep-
ing compression time as short as possible. Dedicated
hemostatic devices have been developed over the past
few years,5,8,9 but the advantages in terms of efficacy
of these tools compared to conventional manual
compression technique have never been demonstrated.
QuikClot R© InterventionalTM bandage (Z-Medica
Corporation, Wallingford, CT, USA) is a novel hemo-
static device, consisting of a pro-coagulant (Kaolin)
agent-filled hydrophilic nonwoven pad that can be
applied topically as an adjunct to manual compression
and is indicated for the local management and control
of surface bleeding from vascular access sites.10,11
When Kaolin comes into contact with blood in a
wound, it rapidly absorbs the smaller water molecules
from the blood. The larger platelets and clotting factor
molecules remain in the wound in a highly concen-
trated form promoting a rapid natural clotting. The aim
of this prospective three-arm randomized study was
to evaluate the safety and efficacy of QuikClot R© in
adjunct to short-time compression, compared to either
short- or prolonged-time compression techniques with
conventional sterile gauzes after transradial diagnostic
or interventional coronary procedures.
Methods
All consecutive patients undergoing transradial elec-
tive diagnostic or interventional coronary procedures
between November 1, 2009 and January 31, 2010 at
the Catheterization Laboratory of Modena University
Hospital were considered to be enrolled in the study.
The only exclusion criteria were an abnormal Allen’s
test before puncture and failure to provide written in-
formed consent. Once the radial access was obtained,
patients were randomized into 3 arms corresponding to
3 different strategies of radial closure. Randomization
was based on a computer-generated randomization list.
Clinical variables were obtained by review of hospital
charts and patient interview; any medication that could
potentially affect bleeding was noted, and systolic and
diastolic blood pressure were measured at the end of
the procedure. Patients receiving chronic warfarin ther-
apy before hospital admission were noted; in all cases,
warfarin was stopped at least 3 days before the proce-
dure until International Normalized Ratio (INR) was
<1.5 and low molecular weight heparin (LMWH) was
administered. The study protocol was approved by the
institutional investigation committees and all patients
signed informed consent.
Radial Access. After sterile preparation and injec-
tion of 2% lidocaine at the puncture site, a 20-gauge
needle was used to enter the radial artery 5 cm above the
crease of the wrist using Seldinger’s technique. On the
appearance of pulsatile flow, a Terumo R© (Terumo Cor-
poration, Tokyo, Japan) 0.018-inches guidewire was
advanced into the radial artery lumen. A 6-Fr glide
sheath was then advanced over the guidewire into the
radial artery (Radifocus R© Introducer II, Terumo Cor-
poration, Tokyo, Japan). Two hundred micrograms of
nitroglycerin or 5 mg of diltiazem were administered
diluted in a 20-mL syringe intraarterially. In addition,
a standard dose of 5,000 IU of unfractionated hep-
arin was administered, followed by additional doses
in case of coronary intervention to achieve and main-
tain activated clotting time (ACT) >250 seconds. The
ACT was measured in all patients at the end of the
procedure from the arterial introducer sheath using the
Hemochron R© (ITC, Edison, NJ, USA) system. All ar-
terial sheaths were removed immediately after the di-
agnostic or interventional procedure irrespectively of
the ACT value.
Randomization to Closure Techniques. After
achieving the radial access and based on a computer-
generated randomization list, patients were allocated
into one of the following strategy groups. Group 1:
the compression of radial artery was obtained with
QuikClot R© InterventionalTM hemostatic pad applied
directly on the skin with a folded gauze over the pad.
All the dressing was then wrapped with adhesive tape
and maintained for 15 minutes. After this period, the
compression was removed leaving the QuikClot R© pad
for 2 hours secured with a TegadermTM (3M Com-
pany, St. Paul, MN, USA) adhesive bandage (Fig. 5).
Group 2: hemostasis was obtained by direct compres-
sion of the radial artery with a folded conventional
sterile gauze wrapped with tape and maintained for
15 minutes only (control group, similar to group 1
without the tested pad). After this period, the compres-
sion was removed leaving a sterile gauze secured with
a TegadermTM adhesive bandage. Group 3: standard
technique consisting of direct compression of the site
of puncture with a folded conventional sterile gauze
wrapped with tape and maintained for 2 hours (con-
ventional strategy).
End-points of the Study. The main end-point was
subacute RAO; the secondary end-point was failure of
the closure technique. Death, myocardial infarction, or
major bleeding occurring in hospital was appraised as
a secondary end-point.
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Radial Artery Occlusion. Radial artery patency
was assessed using the Barbeau’s test12 at 24 hours af-
ter the procedure. The investigator assessing the artery
patency was blinded to the closure technique used. A
pulse oximeter sensor was placed over the index fin-
gertip to obtain a plethysmographic signal. Both radial
and ulnar arteries were compressed to observe a loss
of the plethysmographic signal. Next, the radial artery
was released, and the return of the plethysmographic
signal was observed. A return of the signal confirmed
radial artery flow and, hence, patency. An absence of
the return of the signal was interpreted as RAO. The
ulnar artery was then released to observe the return of
the signal, confirming proper functioning of the equip-
ment. All findings of occlusion were confirmed ultra-
sonographically by another investigator. Efficacy was
defined as a radial artery patency confirmed by the pres-
ence of plethysmographic signal and ultrasonographic
wave 24 hours after the procedure.
Closure Technique Failure. After the scheduled
time of compression (15 minutes for groups 1 and 2 and
2 hours for group 3), the entry site was revised for signs
of active bleeding (acknowledged as failure of the clo-
sure strategy). In case of failure, the compression was
restored using the conventional strategy that was main-
tained for additional 2 hours and observed thereafter
until bleeding stop. Safety was defined as absence of
bleeding from the radial access site after the scheduled
time from sheath removal in the different groups.
Statistical Analysis. Data are expressed as per-
centages or mean ± standard deviation. Analysis was
done by intention-to-treat. Comparison across groups
were performed using Analysis of Variance (ANOVA)
test for continuous variables and Pearson’s chi-square
test or Fisher’s exact test where appropriate for cat-
egorical variables. Receiver operator characteristics
(ROCs) analysis was used to test the value of ACT as-
sociated with greater sensitivity and specificity in pre-
dicting failure of closure technique. Logistic regression
analysis was used to identify univariate predictors of
outcomes. All tests were two-tailed and P < 0.05 was
used for statistical significance. The Statistical Pack-
age for Social Sciences, version 15.0, software (SPSS,
Chicago, IL, USA) was used for analysis.
Results
Clinical and Procedural Data. Of the planned
150 patients (50 for each group), 120 patients were en-
rolled in the study and followed for end-points—50 in
group 1, 20 in group 2, and 50 in group 3. For ethical
reasons, the enrollment in group 2 was stopped after
the 20th patient because of high rate of active bleed-
ing after compression removal (18 out of 20 patients).
Subsequently, the randomization was continued only
for group 1 and 3 until the achievement of 50 patients
per group. Mean age was 61.8 ± 13.2 years, 72.5%
of the patients were male and 15% were diabetics. In-
terventional procedures were performed in 59.2% of
cases. Right radial artery was used in 86.7% of cases,
left radial artery in the remainder. The three groups
were homogenous for baseline and procedural char-
acteristics (Tables 1 and 2). No major adverse events
such as death, myocardial infarction, or major bleed-
ing occurred during the hospitalization in any of the
randomization groups.
Radial Artery Occlusion. None of the patients
enrolled in group 1 developed the main outcome vari-
able. Among patients enrolled in group 2 RAO oc-
curred in 1 case (5%) and among group 3 in 5 cases
(10%) (P = 0.05, Fig. 1). The predictors of RAO in
group 3 were older age (OR 1.09, 95% CI 1.00–1.18,
P= 0.049) and smaller amount of intraprocedural hep-
arin infused (OR 0.70, 95% CI 0.49–0.99, P = 0.044)
(Table 3), while no predictors could be appraised in
group 2.
Failure of Closure Device. Active bleeding after
compression removal occurred in 10 patients (20%) in
group 1, 18 (90%) in group 2, and 1 (2%) in group 3
(P < 0.001, Fig. 2). In all cases, hemostasis was
achieved with a supplementary compression for 2
hours that did not produced any RAO in group 1.
Among patients enrolled in group 1, at univariate anal-
ysis, the only predictors of acute bleeding resulted
chronic therapy with clopidogrel (OR 28.78, 95% CI
4.79–172.82, P < 0.001) and high levels of ACT at the
time of sheath removal (OR 1.02, 95% CI 1.00–1.03,
P= 0.009, Table 4). Among group 2 and group 3, none
of the baseline clinical or procedural variables were
associated with a significantly increased risk of active
bleeding. At ROC analysis, when ACT was below 200
seconds none of the patients developed bleeding in
group 1, while all patients with a value greater than
399 developed it. The cutoff value with a sensitivity
of 80% and specificity of 75% was 287 seconds. The
area under the curve was 0.761 (P < 0.001, Fig. 3).
Clinical Follow-Up. A telephone contact at 6
months was initiated to all 6 patients (1 in group 2 and
5 in group 3) who have experienced RAO. They were
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Table 1. Baseline Characteristics
Variable Group 1 N = 50 Group 2 N = 20 Group 3 N = 50 P Value
Age (years) 64.16 ± 11.53 61.30 ± 14.22 59.72 ± 14.23 0.241
Male sex 37 (74%) 14 (70%) 36 (72%) 0.939
BSA (m2) 1.87 ± 0.15 1.90 ± 0.18 1.93 ± 0.17 0.279
Height (cm) 171.60 ± 8.29 171.20 ± 6.76 171.38 ± 6.69 0.977
Weight (kg) 76.42 ± 11.13 80.00 ± 14.96 82.02 ± 13.26 0.091
Diabetes mellitus 6 (12%) 4 (20%) 8 (16%) 0.676
Hypertension 29 (58%) 13 (65%) 32 (64%) 0.781
Dyslipidemia 29 (58%) 11 (55%) 33 (66%) 0.602
Previous MI 14 (28%) 4 (20%) 12 (24%) 0.766
Previous radial puncture 3 (6%) 2 (10%) 4 (8%) 0.835
Chronic aspirin therapy 46 (92%) 19 (95%) 50 (100%) 0.132
Chronic clopidogrel therapy 10 (20%) 2 (10%) 11 (22%) 0.505
LMWH administration 8 (16%) 5 (25%) 5 (10%) 0.274
Warfarin before hospital admission 6 (12%) 3 (15%) 3 (6%) 0.435
BSA = body surface area; MI = myocardial infarction; LMWH = low molecular weight heparin.
all alive, no major cardiac events occurred, and they
did not notice any discomfort at the arm corresponding
to the site of puncture.
Discussion
Despite the widespread and increasing use of trans-
radial techniques for cardiac and peripheral percuta-
neous procedures, none of the strategy or devices com-
monly used for hemostasis have been able to avoid the
occurrence of RAO, likely because these methods need
prolonged artery compression. In the present study, we
utilized a new compression strategy in order to reduce
the incidence of subacute RAO consisting in applying
the QuikClot R© pad on the radial access with a com-
pression maintained for only 15 minutes, leaving there-
after only the dressing with a simple bandage. This trial
tested the occurrence of 24-hour RAO and the rate of
bleeding after compression removal comparing a short
compression with the QuikClot R© InterventionalTM pad
Table 2. Procedural Characteristics
Group 1 Group 2 Group 3 P Value
Procedural time (minute) 74.20 ± 38.15 68.50 ± 36.63 66.10 ± 32.36 0.516
Systolic blood pressure (mmHg) 126.00 ± 27.77 122.95 ± 19.82 127.50 ± 21.18 0.733
Diastolic blood pressure (mmHg) 78.64 ± 15.15 78.25 ± 9.64 77.96 ± 11.62 0.966
Heparin (IU/103) 6.91 ± 2.96 8.40 ± 3.40 7.74 ± 3.04 0.150
Interventional procedure 24 (48%) 12 (60%) 35 (70%) 0.081
Right radial access 46 (92%) 18 (90%) 40 (80%) 0.188
IIb/IIIa glycoprotein inhibitors 3 (6%) 4 (20%) 7 (14%) 0.205
Activated clotting time at the end of procedure (second) 267.84 ± 71.99 266.10 ± 63.69 267.24 ± 55.82 0.995
versus two other strategies, a short compression and
a conventional prolonged compression both without
QuikClot R© utilization. The main result of the trial is
that QuikClot R© utilization prevents RAO (0 cases com-
pared to 5% and 10%, respectively, in group 2 and 3,
P = 0.05) with a relatively low risk of access site
bleeding after its removal (bleeding occurred in 20%
of cases in group 1 compared to 90% in group 2 and
2% in group 3, P < 0.001). The occurrence of suba-
cute RAO in the conventional group is similar to that
reported in the literature6,7 and much higher than in the
other two groups. This finding underscores the impor-
tance of a short-duration compression to reduce this
complication. The reason of higher rate of RAO in
patients of group 3 than those of group 1 with long
compression after bleeding may be simply related to
higher number of cases (50 vs. 10). Moreover, we as-
sume also that the higher levels of ACT and the more
intense antiplatelets regimen in the 10 patients enrolled
in group 1 may have reduced the risk of RAO. Although
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Figure 1. Incidence of radial artery occlusion at 24 hours (P =
0.05).
20% of bleeding may seem high, it is worth noting that
QuikClot R© failure was associated with a chronic ad-
ministration of double antiplatelet therapy and high
levels of ACT after sheet removal. In particular at the
univariate analysis, patients receiving clopidogrel were
28 times more likely to have early bleeding after com-
pression removal, and ACT values greater than 287
seconds represented a strong predictor of bleeding with
80% sensitivity and 75% specificity. Nevertheless, in
all patients who had QuikClot R© failure, conventional
compression was successfully performed with no fur-
ther bleeding complications.
To date, there are no published studies reporting the
use of QuikClot R© InterventionalTM hemostatic ban-
dage after percutaneous coronary or peripheral proce-
dures associated to a short-time compression to obtain
early closure of radial access without bleeding compli-
cations.
Table 3. Univariate Predictors of Radial Artery Occlusion among
Patients in Group 3
OR 95% CI P Value
Age 1.09 1.00–1.18 0.049
Male sex 4.64 0.68–31.42 0.116
Weight 1.11 0.99–1.24 0.053
Chronic clopidogrel therapy 1.14 0.11–11.41 0.909
LMWH 0.39 0.03–4.39 0.446
Interventional procedure 4.12 0.61–27.78 0.145
Procedural time 1.02 0.98–1.06 0.338
Systolic blood pressure 0.99 0.95–1.03 0.644
IIb/IIIa glycoprotein inhibitor 2.11 0.17–25.92 0.599
Heparin (IU/103) 0.70 0.49–0.99 0.044
Activated clotting time 0.99 0.97–1.01 0.110
Abbreviations as in Table 1.
Figure 2. Incidence of active bleeding after compression removal
(P < 0.001).
The QuikClot system consists of a soft, white, ster-
ile, hydrophilic nonwoven pad that should be applied
topically together with a 3M R© TegadermTM adhesive
bandage. The QuikClot system has been used over the
past 6 years by United States troops in the battlefield
for treating external compressible hemorrhages. Quik-
Clot favors arterial closure by two mechanisms. First,
it acts as a selective sponge by absorbing water and
concentrating coagulation factors at the site of wound.
Second, the pad is filled with Kaolin, a clay mineral
that activates the XII factor of coagulation accelerating
the coagulation cascade (Fig. 4). QuikClot Interven-
tional is a pad simply applicable at the site of puncture
that does not require a learning curve for the opera-
tor or cath lab personnel or a patient monitoring after
removing at the end of 15 minutes compression. This
may be relevant in terms of costs reduction because
the other currently available compression tools (e.g.,
TRband, Terumo Corporation, Japan) usually require
a specific training for nurses or cath lab operators and a
Table 4. Univariate Predictors of Failure of Closure Technique
among Group 1 Patients
OR 95% CI P Value
Age 0.99 0.94–1.06 0.980
Male sex 1.52 0.28–8.28 0.630
BSA 0.50 0.01–45.15 0.760
Ongoing clopidogrel 28.78 4.79–172.82 <0.001
LMWH 0.52 0.57–4.83 0.568
Warfarin before hospital admission 0.78 0.08–7.51 0.828
Interventional procedure 6.00 1.12–31.98 0.036
Procedural time (minute) 0.99 0.98–1.01 0.911
Systolic blood pressure 1.00 0.98–1.03 0.608
IIb/IIIa glycoprotein inhibitors 2.11 0.17–25.92 0.599
Heparin (IU/103) 1.00 1.00–1.00 0.155
Activated clotting time (second) 1.02 1.00–1.02 0.009
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Figure 3. The blue line represents the ROC curve describing the
sensibility and the specificity of ACT in predicting the device failure
(active bleeding after 15 minutes removal) in group 1. As the area
under the curve is 0.761 and the curve is on the left of neutral line
(green), we can assume that ACT has a good accuracy in predicting
the event.
Figure 4. Role of Kaolin in coagulative cascade.
continuous monitoring for progressive compression
decrease related to device deflation.
Clinical Implications
This study demonstrated that QuikClot R© Inter-
ventionalTM is a useful option in the hands of inter-
ventional operators to obtain quick hemostasis of the
radial artery with a reduced risk of RAO compared to
conventional techniques. The present study suggests
that the maximum benefit of this technique can be ob-
tained especially in patients who are not on double
antiplatelets therapy or who have lower values of ACT
at the end of the procedure. Thus, waiting for lower
ACT values before sheath removal is a reasonable op-
tion to reduce device failure.
Strengths and Limitations
To the best of our knowledge, this is the first random-
ized study to compare the QuikClot R© InterventionalTM
70 Journal of Interventional Cardiology Vol. 24, No. 1, 2011
SHORT-TIME RADIAL COMPRESSION WITH KAOLIN-FILLED PAD
Figure 5. Panel A. QuikClot R© InterventionalTM hemostatic pad applied directly on the skin just before removing the radial
sheath. Panel B. Initial brief manual compression with a folded gauze upon the pad. Panel C. Dressing wrapped with adhesive
tape and maintained for 15 minutes. Panel D. The compression is removed leaving the QuikClot R© InterventionalTM secured
with a TegadermTM adhesive bandage.
for radial access closure in comparison to conventional
techniques in a series of consecutive patients under-
going coronary angiography or angioplasty. Because
this was a trial testing a new device and a new tech-
nique, the number of participants was limited to that
necessary to test the main study end-point. However,
the limited number of exclusion criteria enhances the
generalizability of the results. We have not assessed
chronic RAO by Barbeau’s test; therefore, it may be
that some patients with RAO at 24 hours in group 3
would eventually recanalize at 30 days as previously
shown.13 However, the advantage of QuikClot in group
1 remains evident as no patient developed RAO. Sim-
ilarly to other small size trials with minor hazards,
there was not an external independent safety moni-
toring board, but the study investigators monitored the
study for the occurrence of adverse effects. Indeed, due
to an unexpectedly high level of failure in one group,
the study investigators decided to stop early one arm
of the study for futility. Of note such complication
was minor, and none of the patients enrolled in the
trial developed major adverse events. Finally, there is
an imbalance in interventional procedures with elective
or bailout IIb/IIIaglycoprotein inhibitors-inhibitors ad-
ministration among group 1 and 3. This is the result
of a blind randomization performed before coronary
angiography that could have produced an underesti-
mation of RAO incidence in group 3 for the higher
antiplatelets regimen respect to group 1.
Conclusions
The present randomized clinical trial demonstrated
for the first time that a novel hemostatic technique
based on QuikClot R© InterventionalTM pad utilization
combined with short-time compression is significantly
superior to conventional compression technique in re-
ducing the risk of RAO after percutaneous transradial
coronary procedures. Furthermore, the study shows
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that early sheet removal and short-time compression
with QuikClot R© InterventionalTM is safe and effec-
tive especially in patients not on double antiplatelet
therapy and can be performed routinely after diagnos-
tic or interventional procedures. Despite QuikClot R©
InterventionalTM application, early sheet removal with
an ACT higher than 287 seconds or in patients taking
chronic dual antiplatelet therapy should be cautious
due to the risk of hemorrhage at the puncture site.
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